Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Cervical Cancer

  Free Subscription


1 AAPS PharmSciTech
1 Am J Epidemiol
1 Beijing Da Xue Xue Bao Yi Xue Ban
1 Biochem Genet
1 Biochim Biophys Acta Rev Cancer
1 Biomol Ther (Seoul)
1 Bioorg Chem
1 BMC Cancer
1 BMC Womens Health
1 Cancer Rep (Hoboken)
1 Cells
1 Clin Microbiol Infect
1 Clin Radiol
2 Cureus
1 Eur J Cancer
2 Eur J Obstet Gynecol Reprod Biol
1 Eur Radiol Exp
3 Front Oncol
1 Front Public Health
1 Future Med Chem
1 Glob Health Action
1 Gynecol Oncol Rep
2 Heliyon
1 Hum Vaccin Immunother
1 Int J Cancer
1 Int J Gynecol Cancer
1 Int J Mol Med
1 J Cancer Educ
1 J Cancer Policy
1 J Cell Physiol
1 J Contemp Brachytherapy
1 J Gynecol Oncol
1 J Inorg Biochem
1 J Med Virol
1 J Obstet Gynaecol
1 J Obstet Gynaecol Res
1 J Pharm Biomed Anal
2 J Womens Health (Larchmt)
2 Medicine (Baltimore)
1 medRxiv
1 Mol Ther Oncol
1 Open Life Sci
1 Open Med (Wars)
2 Patient Educ Couns
1 PLoS One
1 Radiat Oncol
2 Sci Rep
2 Technol Cancer Res Treat
1 Technol Health Care
1 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AAPS PharmSciTech

  1. SAHA I, Halder J, Rajwar TK, Mahanty R, et al
    Novel Drug Delivery Approaches for the Localized Treatment of Cervical Cancer.
    AAPS PharmSciTech. 2024;25:85.
    PubMed         Abstract available

    Am J Epidemiol

  2. GOPALANI SV, Sawaya GF, Rositch AF, Dasari S, et al
    The Impact of Adjusting for Hysterectomy Prevalence on Cervical Cancer Incidence Rates and Trends Among Women Aged 30 Years and Older - United States, 2001-2019.
    Am J Epidemiol. 2024 Apr 6:kwae041. doi: 10.1093.
    PubMed         Abstract available

    Beijing Da Xue Xue Bao Yi Xue Ban

  3. LIN G, Ma C, Wu C, Si Y, et al
    [Application of microchannel technique in minimally invasive resection of cervical intraspinal tumors].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2024;56:318-321.
    PubMed         Abstract available

    Biochem Genet

  4. BAI Y, Miao Y, Wang J, Gan J, et al
    Predictive Value and Immunological Role of the HSPA5 Gene in Cervical Cancer.
    Biochem Genet. 2024 Apr 8. doi: 10.1007/s10528-024-10782.
    PubMed         Abstract available

    Biochim Biophys Acta Rev Cancer

  5. LIU Y, Yan Q, Zeng Z, Fan C, et al
    Advances and prospects of mRNA vaccines in cancer immunotherapy.
    Biochim Biophys Acta Rev Cancer. 2024;1879:189068.
    PubMed         Abstract available

    Biomol Ther (Seoul)

  6. CHOI SY, Kim S, Jeon JY, Kim MG, et al
    Metabolomic Profiles in Patients with Cervical Cancer Undergoing Cisplatin and Radiation Therapy.
    Biomol Ther (Seoul). 2024 Apr 9. doi: 10.4062/biomolther.2023.
    PubMed         Abstract available

    Bioorg Chem

  7. LIU Z, Yang Z, Ablise M
    Design and synthesis of novel imidazole-chalcone derivatives as microtubule protein polymerization inhibitors to treat cervical cancer and reverse cisplatin resistance.
    Bioorg Chem. 2024;147:107310.
    PubMed         Abstract available

    BMC Cancer

  8. NAKISIGE C, de Fouw M, Nakalembe M, Orem J, et al
    Baseline knowledge on risk factors, symptoms and intended behavior of women and men towards screening and treatment of cervical cancer in rural Uganda: a cross-sectional study.
    BMC Cancer. 2024;24:450.
    PubMed         Abstract available

    BMC Womens Health

  9. XU M, Wang Y
    Clinical characteristics, HPV involvement, and demographic risk factors in women with cervical intraepithelial neoplasia complicated by vaginal intraepithelial neoplasia.
    BMC Womens Health. 2024;24:220.
    PubMed         Abstract available

    Cancer Rep (Hoboken)

  10. KHOSHNAZAR MS, Tarrahi MJ, Shahnazi H
    Impact of virtual education based on health belief model on cervical cancer screening behavior in middle-aged women: A quasi-experimental study.
    Cancer Rep (Hoboken). 2024;7:e2058.
    PubMed         Abstract available


  11. BUENO-URQUIZA LJ, Godinez-Rubi M, Villegas-Pineda JC, Vega-Magana AN, et al
    Phenotypic Heterogeneity of Cancer Associated Fibroblasts in Cervical Cancer Progression: FAP as a Central Activation Marker.
    Cells. 2024;13:560.
    PubMed         Abstract available

    Clin Microbiol Infect

  12. YIN J, Zhang S, Li Z, Li Y, et al
    Impact of high-performance HPV testing to improve cervical cancer screening in China: A prospective population-based multicenter cohort study.
    Clin Microbiol Infect. 2024 Apr 8:S1198-743X(24)00166.
    PubMed         Abstract available

    Clin Radiol

  13. LIU B, Gao H, Zhou F, Zhao W, et al
    Dynamic contrast-enhanced magnetic resonance imaging in cervical cancer: correlation between quantitative parameters and molecular markers hypoxia-inducible factors-1-alpha, vascular endothelial growth factor, and Ki-67.
    Clin Radiol. 2024 Mar 15:S0009-9260(24)00128-4. doi: 10.1016/j.crad.2024.
    PubMed         Abstract available


  14. CHEN J, Zhang R, Xu W, Bai L, et al
    Knowledge and Practices Regarding Human Papillomavirus and Cervical Cancer Screening Among Women in Low-Income Areas of China: A Cross-Sectional Study.
    Cureus. 2024;16:e55930.
    PubMed         Abstract available

  15. NUZHATH FJ, Patil NJ, Sheela SR, Manjunath GN, et al
    A Randomized Controlled Trial on Pranayama and Yoga Nidra for Anxiety and Depression in Patients With Cervical Cancer Undergoing Standard of Care.
    Cureus. 2024;16:e55871.
    PubMed         Abstract available

    Eur J Cancer

  16. TUNINETTI V, Virano E, Salutari V, Ricotti A, et al
    Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
    Eur J Cancer. 2024;203:114039.
    PubMed         Abstract available

    Eur J Obstet Gynecol Reprod Biol

  17. LUO Y, Ma X
    Construction and efficacy test of a survival prediction model for locally advanced cervical cancer based on anti-angiogenesis.
    Eur J Obstet Gynecol Reprod Biol. 2024;297:72-77.
    PubMed         Abstract available

  18. CEA GARCIA J, Rodriguez Jimenez I, Marquez Maraver F, Rios-Pena L, et al
    Quality of life in long-term cervical cancer survivors compared with healthy women and women with benign gynecological disorders.
    Eur J Obstet Gynecol Reprod Biol. 2024;297:78-85.
    PubMed         Abstract available

    Eur Radiol Exp

  19. LIN G, Hsieh CY, Lai YC, Wang CC, et al
    Hyperpolarized [1-(13)C]-pyruvate MRS evaluates immune potential and predicts response to radiotherapy in cervical cancer.
    Eur Radiol Exp. 2024;8:46.
    PubMed         Abstract available

    Front Oncol

  20. BARQUET-MUNOZ SA, Arteaga-Gomez C, Diaz-Lopez E, Rodriguez-Trejo A, et al
    Current status and challenges in timely detection of cervical cancer in Mexico: expert consensus.
    Front Oncol. 2024;14:1383105.
    PubMed         Abstract available

  21. FINCH LA, Levy MS, Thiele A, Jeudin P, et al
    Barriers to cervical cancer prevention in a safety net clinic: gaps in HPV vaccine provider recommendation and series completion among Ob/Gyn patients.
    Front Oncol. 2024;14:1359160.
    PubMed         Abstract available

  22. GUTIERREZ SALMEAN G, Delgadillo Gonzalez M, Rueda Escalona AA, Leyva Islas JA, et al
    Effects of prebiotics, probiotics, and synbiotics on the prevention and treatment of cervical cancer: Mexican consensus and recommendations.
    Front Oncol. 2024;14:1383258.
    PubMed         Abstract available

    Front Public Health

  23. YAO X, Li Q, Chen Y, Du Z, et al
    Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023.
    Front Public Health. 2024;12:1332696.
    PubMed         Abstract available

    Future Med Chem

  24. SONKER P, Tamang R, Mehata AK, Nidhar M, et al
    PTSA-induced synthesis, in silico and nano study of novel ethylquinolin-thiazolo-triazole in cervical cancer.
    Future Med Chem. 2024 Apr 10. doi: 10.4155/fmc-2023-0344.
    PubMed         Abstract available

    Glob Health Action

  25. NAAMALA A, Eriksson LE, Orem J, Nalwadda GK, et al
    Health-related quality of life among adult patients with cancer in Uganda - a cross-sectional study.
    Glob Health Action. 2024;17:2325728.
    PubMed         Abstract available

    Gynecol Oncol Rep

  26. SSEDYABANE F, Ngonzi J, Tusubira D, Nambi Najjuma J, et al
    Association between serum P16ink4A concentration and CIN and cervical cancer among women attending a cervical cancer clinic in western Uganda: A case control study.
    Gynecol Oncol Rep. 2024;53:101388.
    PubMed         Abstract available


  27. JIANG R, Li X, Cao S, Wu Y, et al
    Nodal staging score for adequacy of nodal staging in cervical cancer.
    Heliyon. 2024;10:e26116.
    PubMed         Abstract available

  28. JIBAT N, Ali R, Adissu W, Buruh G, et al
    Less known but greatly feared: Cervical cancer in Ethiopia community awareness.
    Heliyon. 2024;10:e28328.
    PubMed         Abstract available

    Hum Vaccin Immunother

  29. ZHAO C, Zhao Y, Li J, Li M, et al
    Opportunities and challenges for human papillomavirus vaccination in China.
    Hum Vaccin Immunother. 2024;20:2329450.
    PubMed         Abstract available

    Int J Cancer

  30. DOWNHAM L, Rol ML, Forestier M, Romero P, et al
    Field experience with the 8-HPV-type oncoprotein test for cervical cancer screening among HPV-positive women living with and without HIV in LMICs.
    Int J Cancer. 2024 Apr 11. doi: 10.1002/ijc.34953.
    PubMed         Abstract available

    Int J Gynecol Cancer

  31. KOHLER C, Plaikner A, Siegler K, Hertel H, et al
    Radical vaginal trachelectomy: long-term oncologic and fertility outcomes in patients with early cervical cancer.
    Int J Gynecol Cancer. 2024 Apr 10:ijgc-2024-005274.
    PubMed         Abstract available

    Int J Mol Med

  32. LIZANO M, Carrillo-Garcia A, De La Cruz-Hernandez E, Castro-Munoz LJ, et al
    Promising predictive molecular biomarkers for cervical cancer (Review).
    Int J Mol Med. 2024;53:50.
    PubMed         Abstract available

    J Cancer Educ

  33. LOHR AM, Capetillo GP, Molina L, Goodson M, et al
    Development of a Digital Storytelling Intervention to Increase Breast, Cervical, and Colorectal Cancer Screening in the Hispanic/Latino Community: a Qualitative Evaluation.
    J Cancer Educ. 2024;39:160-167.
    PubMed         Abstract available

    J Cancer Policy

  34. ADAMS RA, Botha MH
    Cervical cancer prevention in Southern Africa: a review of national cervical cancer screening guidelines in the Southern African Development Community.
    J Cancer Policy. 2024 Apr 7:100477. doi: 10.1016/j.jcpo.2024.100477.
    PubMed         Abstract available

    J Cell Physiol

  35. Retraction: "Downregulation of microRNA-205 inhibits cell invasion and angiogenesis of cervical cancer through TSLC1-mediated Akt signaling pathway".
    J Cell Physiol. 2024 Apr 9. doi: 10.1002/jcp.31239.
    PubMed         Abstract available

    J Contemp Brachytherapy

  36. JAMADAGNI S, Ponni Tr A, P R
    Dosimetric comparison of intra-cavitary brachytherapy technique with free-hand (intra-cavitary + interstitial) technique in cervical cancer.
    J Contemp Brachytherapy. 2024;16:28-34.
    PubMed         Abstract available

    J Gynecol Oncol

  37. FANG C, Zhou Y, Feng Y, He L, et al
    QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial.
    J Gynecol Oncol. 2024 Mar 29. doi: 10.3802/jgo.2024.
    PubMed         Abstract available

    J Inorg Biochem

  38. WELSH A, Matshitse R, Khan SF, Nyokong T, et al
    Trinuclear ruthenium(II) polypyridyl complexes: Evaluation as photosensitizers for enhanced cervical cancer treatment.
    J Inorg Biochem. 2024;256:112545.
    PubMed         Abstract available

    J Med Virol

  39. MAITRA S, Mukerjee N, Alharbi HM, Ghosh A, et al
    Targeted therapies for HPV-associated cervical cancer: Harnessing the potential of exosome-based chipsets in combating leukemia and HPV-mediated cervical cancer.
    J Med Virol. 2024;96:e29596.
    PubMed         Abstract available

    J Obstet Gynaecol

  40. ZHANG Y, Li L, Han Q, Wen L, et al
    The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis.
    J Obstet Gynaecol. 2024;44:2333784.
    PubMed         Abstract available

    J Obstet Gynaecol Res

  41. UEDA Y
    Epidemiology of cervical cancer and HPV infection in Asia and Oceania.
    J Obstet Gynaecol Res. 2024 Apr 8. doi: 10.1111/jog.15943.
    PubMed         Abstract available

    J Pharm Biomed Anal

  42. EL-NASHAR HAS, Al-Azzawi MA, Al-Kazzaz HH, Alghanimi YK, et al
    HPLC-ESI/MS-MS metabolic profiling of white pitaya fruit and cytotoxic potential against cervical cancer: Comparative studies, synergistic effects, and molecular mechanistic approaches.
    J Pharm Biomed Anal. 2024;244:116121.
    PubMed         Abstract available

    J Womens Health (Larchmt)

  43. ROSENBLUM HG, Gargano JW, Cleveland AA, Dahl RM, et al
    U.S. Women with Invasive Cervical Cancer: Characteristics and Potential Barriers to Prevention.
    J Womens Health (Larchmt). 2024 Apr 12. doi: 10.1089/jwh.2023.0462.
    PubMed         Abstract available

  44. COCHRANE AC, Bullington BW, Prokopowicz C, Rahangdale L, et al
    Comparing Cervical Cancer Screening Strategies in an Incarcerated Population.
    J Womens Health (Larchmt). 2024 Apr 12. doi: 10.1089/jwh.2023.0513.
    PubMed         Abstract available

    Medicine (Baltimore)

  45. LI X, Ou C, He A
    Construction of artificial neural network (ANN) based on predictive value of prognostic nutritional index (PNI) and neutrophil-to-lymphocyte ratio (NLR) in patients with cervical squamous cell carcinoma.
    Medicine (Baltimore). 2024;103:e37680.
    PubMed         Abstract available

  46. ZHAO X, Fan X, Lin X, Guo B, et al
    Deciphering age-specific molecular features in cervical cancer and constructing an angio-immune prognostic model.
    Medicine (Baltimore). 2024;103:e37717.
    PubMed         Abstract available


  47. MUNGO C, Ellis GK, Rop M, Zou Y, et al
    Perceived acceptability of self-administered topical therapy for cervical precancer treatment among women undergoing cervical cancer screening in Kenya.
    medRxiv [Preprint]. 2024 Mar 6:2024.03.05.24303779.
    PubMed         Abstract available

    Mol Ther Oncol

  48. WANG D, Zou F, Li Y, Hu J, et al
    Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity.
    Mol Ther Oncol. 2024;32:200759.
    PubMed         Abstract available

    Open Life Sci

  49. LI Y, Man X, Zhang Q, Wang X, et al
    Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner.
    Open Life Sci. 2024;19:20220819.
    PubMed         Abstract available

    Open Med (Wars)

  50. SONG C, Chen L
    Circ_0051428 targeting miR-885-3p/MMP2 axis enhances the malignancy of cervical cancer.
    Open Med (Wars). 2024;19:20230858.
    PubMed         Abstract available

    Patient Educ Couns

    The potential influence of patient-centered communication, online provider communication, and social determinants of health on cancer screening.
    Patient Educ Couns. 2024;123:108238.
    PubMed         Abstract available

  52. LI J
    Relationships among health-related social media use, knowledge, worry, and cervical cancer screening: A cross-sectional study of US females.
    Patient Educ Couns. 2024;124:108283.
    PubMed         Abstract available

    PLoS One

  53. LEMLEM SB, Gary RA, Yeager KA, Sisay MM, et al
    Psychometric properties of a modified health belief model for cervical cancer and visual inspection with acetic acid among healthcare professionals in Ethiopia.
    PLoS One. 2024;19:e0295905.
    PubMed         Abstract available

    Radiat Oncol

  54. LI W, Ma L, Li F, Li K, et al
    Effects of bone marrow sparing radiotherapy on acute hematologic toxicity for patients with locoregionally advanced cervical cancer: a prospective phase II randomized controlled study.
    Radiat Oncol. 2024;19:46.
    PubMed         Abstract available

    Sci Rep

  55. KIM H, Yoo SK, Kim JS, Kim YT, et al
    Clinical feasibility of deep learning-based synthetic CT images from T2-weighted MR images for cervical cancer patients compared to MRCAT.
    Sci Rep. 2024;14:8504.
    PubMed         Abstract available

  56. ABATE A, Munshea A, Nibret E, Alemayehu DH, et al
    Characterization of human papillomavirus genotypes and their coverage in vaccine delivered to Ethiopian women.
    Sci Rep. 2024;14:7976.
    PubMed         Abstract available

    Technol Cancer Res Treat

  57. WANG SF, Du CY, Li M, Wen B, et al
    Endometrial Cancer Detection by DNA Methylation Analysis in Cervical Papanicolaou Brush Samples.
    Technol Cancer Res Treat. 2024;23:15330338241242637.
    PubMed         Abstract available

  58. WU Z, Liu M, Pang Y, Deng L, et al
    A Comparative Study of Deep Learning Dose Prediction Models for Cervical Cancer Volumetric Modulated Arc Therapy.
    Technol Cancer Res Treat. 2024;23:15330338241242654.
    PubMed         Abstract available

    Technol Health Care

  59. LI C, Li J, Lu Y, Hou J, et al
    Observations of the effectiveness, dosage, and prognosis of intensity-modulated radiation therapy under ultrasonic guidance for cervical cancer patients.
    Technol Health Care. 2024 Feb 29. doi: 10.3233/THC-231977.
    PubMed         Abstract available


  60. MALDONADO I, Rodriguez Nino N, Valencia CF, Ortiz D, et al
    Evaluation of the safety profile of the quadrivalent vaccine against human papillomavirus in the risk of developing autoimmune, neurological, and hematological diseases in adolescent women in Colombia.
    Vaccine. 2024 Mar 7:S0264-410X(24)00263-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.